Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00335673
Status:
COMPLETED
Last Update Posted:
2011-04-01
First Post:
2006-06-09
Brief Title:
I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Irbesartan in Mild to Moderate Hypertensive Patients
Status:
COMPLETED
Status Verified Date:
2011-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate control rate of Blood Pressure 14090 mm Hg in non-diabetic patients and 13080 mm Hg in diabetic patients
To determine percentage of patients achieving blood pressure control according to their profile naïve switch patient history etc at the end of the trial
To determine percentage of patients achieving blood pressure control according to their profile naïve switch patient history etc at the end of the trial
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None